Prognostic Significance of Neutropenia on Day One of Anthracycline-Based Neoadjuvant Chemotherapy in Operable Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|78|3-4|213-219

ISSN： 0030-2414

Source： Oncology, Vol.78, Iss.3-4, 2010-04, pp. : 213-219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incidence and Predictors of Febrile Neutropenia among Early-Stage Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy in Korea

By  

Oncology, Vol. 91, Iss. 5, 2016-09 ,pp. : 274-282

Karger

Access to resources Recommend Favorite

Tumor Topoisomerase II Alpha Status and Response to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer

By  

Oncology, Vol. 80, Iss. 3-4, 2011-07 ,pp. : 269-277

Karger

Access to resources Recommend Favorite

Serial Topoisomerase II Expression in Primary Breast Cancer and Response to Neoadjuvant Anthracycline-Based Chemotherapy

By  

Oncology, Vol. 66, Iss. 5, 2004-09 ,pp. : 388-394

Karger

Access to resources Recommend Favorite

Clinical and Pathological Features of Breast Cancer Associated with the Pathological Complete Response to Anthracycline-Based Neoadjuvant Chemotherapy

By  

Oncology, Vol. 81, Iss. 1, 2011-09 ,pp. : 30-38

Karger

Access to resources Recommend Favorite

Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer

By  

ANZ JOURNAL OF SURGERY, Vol. 85, Iss. 5, 2015-05 ,pp. : 315-320

John Wiley & Sons Inc

Access to resources Recommend Favorite